Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published July 2003 | public
Journal Article

The role of Staphylococcus aureus sortase A and sortase B in murine arthritis

Abstract

Gram-positive pathogenic bacteria display proteins on their surface that play important roles during infection. In Staphylococcus aureus, these surface proteins are anchored to the cell wall by two sortase enzymes, SrtA and SrtB, that recognize specific surface protein sorting signals. The role of sortase enzymes in bacterial virulence was examined using a murine septic arthritis model. Intravenous inoculation with any of the Δ(srtA), Δ(srtB) or Δ(srtAB) mutants resulted in significantly increased survival and significantly lower weight loss compared with the parental strain. Mice inoculated with the Δ(srtA) mutant did not express severe arthritis, while arthritis in mice inoculated with the Δ(srtB) mutant was not different from that seen in mice that were infected with the wild-type parent strain. Furthermore, persistence of staphylococci in kidneys and joints following intravenous inoculation of mice was more pronounced for wild-type and Δ(srtB) mutant strains than for Δ(srtA) or Δ(srtAB) variants. Together these results indicate that sortase B (srtB) plays a contributing role during the pathogenesis of staphylococcal infections, whereas sortase A (srtA) is an essential virulence factor for the establishment of septic arthritis.

Additional Information

© 2003 Published by Elsevier Masson SAS. Received 27 January 2003, Accepted 4 April 2003, Available online 5 June 2003. We thank Lena Svensson and Berit Ericsson for excellent technical assistance. This work was supported by grants from the Gothenburg Medical Society, the Swedish Association against Rheumatism, the King Gustav V 80 Years Foundation, the Inflammation network, the Infection and Vaccination network, the Nanna Svartz Foundation, the Swedish Medical Research Council, the Börje Dahlin Foundation, Rune and Ulla Amlöfs foundation, The University of Gothenburg, the A-G Crafoord Foundation, and A.M.E. Wolffs Foundation. Work in the laboratory of O.S. was supported by United States Public Health Service Grants AI38897 and AI52474 from the NIH-NIAID Infectious Diseases Branch.

Additional details

Created:
August 22, 2023
Modified:
October 19, 2023